Also, the etiologies for cancers, Alzheimer's disease and other areas of clinical interest are considered likely to benefit from genome information and possibly may lead in the long term to significant advances in their management.
Ademais, as etioloxías de cancros, enfermidade de Alzheimer e outras áreas de interese clínico son consideradas probablemente beneficiarias da información do xenoma e posiblemente poden levar a longo prazo a avances significativos nos tratamentos.